The therapy also drove additional weight loss at the higher 1.8 mg dose without plateauing and maintained a favorable tolerability profile
The initiative is focused on a problem that continues to plague cancer outcomes in India
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
The company shall process the change of name application with BSE Ltd. in due course
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
The inspection concluded with one minor observation in Form 483
Updated results from the EMBER-3 study showed that the drug -- Inluriyo (imlunestrant) -- as a standalone treatment cut the risk of progression or death by 38%
Subscribe To Our Newsletter & Stay Updated
